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ABSTRACT
Invasive meningococcal disease continues to be a life-threatening condition and rapid diagnosis is
important for the administration of appropriate treatment. This study focused on the use of PCR for the
diagnosis of meningococcal aetiology and the dynamics of PCR-based diagnosis over time in various
biological samples. Sixty cerebrospinal ﬂuid (CSF) and 144 serum samples collected during the ﬁrst
week of hospitalisation from 37 patients with laboratory-conﬁrmed invasive meningococcal disease
were investigated. Overall, 91.9% of CSF samples and 45.9% of serum samples were PCR-positive,
while culture of CSF and blood was positive for only 35% and 39% samples, respectively. Positive PCR
results were obtained until day 7 with CSF and until day 5 with serum. It is therefore recommended that
samples for molecular diagnosis should be collected early in the course of suspected invasive
meningococcal disease.
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INTRODUCTION
Invasive disease (sepsis and ⁄ or meningitis)
caused by Neisseria meningitidis is a potentially
life-threatening condition that can also lead to
life-long disﬁgurement. Clinical suspicion of this
infection is usually based on the presence of
haemorrhagic skin rash associated with symp-
toms of meningitis or acute sepsis. Rapid and
accurate diagnosis is essential both for optimal
management of patients and for timely antibiotic
prophylaxis for contacts. Conﬁrmation of the
aetiological diagnosis allows physicians to use
narrow-spectrum antibiotics, to shorten the dur-
ation of treatment and to provide prognostic
information.
Conventional microscopy, as well as culture
methods, may fail to allow the diagnosis of
invasive meningococcal disease (IMD) because
of early administration of antibiotics. Blood
cultures are positive in c. 50% of untreated
patients with meningococcal sepsis, but this
positivity rate is reduced to 5% after the ﬁrst
dose of antibiotic. Similarly, microscopy or cul-
ture is positive with cerebrospinal ﬂuid (CSF)
samples in 90% of untreated cases of meningo-
coccal meningitis, but there is a dramatic reduc-
tion if antibiotics have been administered
previously [1]. PCR detects small quantities of
bacterial DNA and does not require the presence
of viable bacteria. Therefore, it can conﬁrm the
aetiological agent even after antibiotic adminis-
tration. Moreover, PCR can determine the sero-
group of meningococci involved. Serogroup
classiﬁcation of meningococcal isolates is useful
for epidemiological surveillance, for case ⁄ contact
management, and for monitoring the effective-
ness of meningococcal vaccines. Detection of
meningococcal DNA in biological samples has
been achieved with primers based on the 16S
rRNA gene [2,3], and more speciﬁc primers can be
used for serogroup identiﬁcation (siaD gene for
serogroups B, C, Y and W135, and mynB ⁄ sacC
gene for serogroup A) [4,5]. Fluorescence- and
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gel-based methods have been developed for
visualisation and identiﬁcation of PCR products
[6–8].
In the Czech Republic, an active surveillance
programme registers c. 100 cases of IMD annu-
ally, with a reported case fatality rate of c. 10%
[9]. Since 2001, PCR has been used increasingly
for laboratory conﬁrmation and epidemiological
surveillance of IMD in the Czech Republic. In
2003, the aetiology of 41.6% of all registered cases
of IMD was conﬁrmed by PCR. Moreover, PCR
was the only method that enabled the aetiology to
be conﬁrmed for 17.8% of cases [10]. Since 2003,
guidelines for pre-hospital management of sus-
pected cases of IMD in the Czech Republic have
recommended intravenous administration of the
ﬁrst dose of antibiotic and corticosteroid before
transport to the hospital, with blood for culture
and PCR being taken before treatment is started
[11]. Conﬂicting ﬁndings have been published
concerning the dynamics of bacterial DNA stabil-
ity in various biological samples. This information
could contribute to a better understanding of the
pathophysiology of IMD, as well as indicating
the most appropriate time for taking samples. The
aim of the present study was to determine the
dynamics of PCR-based diagnosis in blood and
CSF samples, and to compare the efﬁcacies of
different PCR primer pairs.
MATERIALS AND METHODS
Patients
The individuals included in this prospective study were
patients with positive PCR results from CSF and ⁄ or blood,
hospitalised at the Department of Infectious Diseases of the
University Hospital, Prague, between January 2002 and March
2004, who fulﬁlled one of the following criteria: (1) culture
isolation of N. meningitidis from a normally sterile site (n = 20);
or (2) typical clinical symptoms and positive latex agglutin-
ation (LA) test or direct microscopy (n = 5); or (3) typical
clinical symptoms and no other aetiological agent conﬁrmed
(n = 12). Typical clinical symptoms were deﬁned as: haemor-
rhagic skin rash (petechiae and ecchymoses) and presence of
symptoms of sepsis ⁄ septic shock and ⁄ or meningitis. Accord-
ing to these criteria, 37 patients (20 males, 17 females; mean
age 23.1 years; range 6 months to 58 years) were included in
the study. Nine (24%) patients were diagnosed with sepsis and
28 (76%) with meningitis.
Collection and handling of specimens
For PCR, serum or whole blood samples were taken on the day
of admission and during the ﬁrst week of hospitalisation. CSF
was collected on the day of admission and usually on day 5
after admission, or earlier if the patient’s condition was not
improving as expected. Sixty CSF samples and 144 blood
samples were collected from 37 patients. Blood samples were
stored at 4C and CSF samples at ) 20C. On the day of
admission, biological material was sampled for direct micro-
scopy, culture and LA tests. Antibiotic therapy was started on
the day of admission or before hospitalisation. The day when
therapy was started was recorded as day 0. Following
admission, all patients were treated under standard regimens
with cefotaxime or benzylpenicillin. Clinical data were
obtained from medical reports and the physicians involved
in treatment. Informed consent was received from the parents
or guardians of all patients. The research was carried out in
accordance with the Helsinki Declaration.
PCR
DNA was extracted from blood or serum (200 lL) and the
sediment was obtained following centrifugation of c. 1 mL of
CSF with a QIAamp DNA Mini Kit (QIAGEN, Hilden,
Germany). Primers used for PCR are listed in Table 1; crgA
and nested 16S rRNA primers were used to detect
N. meningitidis, and siaD primers were used to identify
serogroups B and C. Reaction mixtures (50 lL) consisted
of 10 mM Tris-HCl (pH 8.8), 50 mM KCl, Triton X-100 0.1%
v ⁄v, 1.5 mM MgCl2, 0.2 mM dNTPs (Biogen, Prague, Czech
Republic), 0.5 lM primers, 0.5 U of recombinant Taq DNA
polymerase (Top-Bio, Prague, Czech Republic) and 25 lL of
DNA extract. Ampliﬁcation was performed in an Amplitron II
Thermocycler (Thermolyne, Dubuque, IA, USA) as follows:
94C for 2 min, followed by 35 cycles of 94C for 1 min, 55C
Table 1. Oligonucleotide primers used for PCR
PCR assay Oligonucleotides Gene Sequences
Amplicon
(bp) Species
One step 98-6 crgA 5¢-GCTGGCGCCGCTGGCAACAAATTC-3¢ 230 Neisseria meningitidis
98-10 5¢-CTTCTGCAGATTGCGGCGTGCCTG-3¢
98-19 siaD 5¢-GGATCATTTCAGTGTTTTCCACCA-3¢ 450 N. meningitidis B
98-20 5¢-GCATGCTGGAGGAATAAGCATTAA-3¢
98-17 siaD 5¢-TCAAATGAGTTTGCGAATAGAAGGT-3¢ 250 N. meningitidis C
98-18 5¢-CAATCACGATTTGCCCAATTGAC-3¢
Semi-nested
Step I U3 16S rRNA 5¢-AACT(C ⁄A)CGTGCCAGCAGCCGCGGTAA-3¢ 1031 Bacteria
ru8 16S rRNA 5¢-AAGGAGGTGATCCA(G ⁄A)CCGCA(G ⁄C)(G ⁄C)TTC-3¢
Step II NM 16S rRNA 5¢-TGTTGGGCAACCTGATTG-3¢ 710 N. meningitidis
ru8 16S rRNA 5¢-AAGGAGGTGATCCA(G ⁄A)CCGCA(G ⁄C)(G ⁄C)TTC-3¢
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for 1 min and 72C for 1 min, followed by 72C for 2 min. This
ﬁrst-step reaction was then diluted 1:500 in sterile, DNA-free
water, and 5 lL was added to a second reaction, which
consisted of 20 cycles. Each PCR run included negative (water)
and positive controls. The PCR products were visualised
under UV light following electrophoresis on agarose 2% w ⁄v
gels and staining with ethidium bromide. Amplicon sizes are
listed in Table 1.
Conventional identiﬁcation
CSF and blood samples from patients with suspected IMD
were sent to the microbiological laboratory for direct micro-
scopy and culture. N. meningitidis strains were cultured on
blood agar plates at 37C in CO2 5% v ⁄v for 48 h. Commer-
cially available LA kits were used for direct testing of CSF
(Slides me´ningite-Kit 5; bioMe´rieux, Marcy l’Etoile, France)
and blood (Pastorex meningitis kit; Bio-Rad, Marnes-
la-Coquette, France) with one drop (30–40 lL) of biological
sample according to the manufacturers’ instructions.
Statistical analysis
Results of diagnostic methods were expressed as percentages.
Results of tests performed before and after the onset of
antibiotic treatment were compared using Fisher’s exact test
and GraphPad Prism v. 4.00 (Graph Pad Software, San Diego,
CA, USA). The level of statistical signiﬁcance was deﬁned as
p £ 0.05.
RESULTS
Positive PCR results were obtained for 17 (45.9%)
blood samples and 34 (91.9%) CSF samples. In 15
(40%) cases, positive results were obtained with
both sample types. Based on the PCR results, the
infecting organisms belonged to serogroup B
(n = 17; 46%), serogroup C (n = 15; 41%) or
serogroup Y (n = 1; 3%), or else the serogroup
was not determined (n = 4; 10%). Twenty (54%)
patients had received antibiotics before collection
of blood for PCR, and 16 (43%) patients received
antibiotics before collection of CSF samples.
In contrast to PCR, there were 14 (39%) positive
blood cultures and 13 (35%) positive CSF cul-
tures. Ten (28%) patients received antibiotics
before collection of blood for culture, and 14
(38%) received antibiotics before collection of CSF
for culture. In the group of pretreated patients,
there was a signiﬁcant reduction in the frequency
of culture-positive results (p 0.01) and a non-
signiﬁcant reduction in the frequency of LA-
positive results. The frequency of positive PCR
results was not changed signiﬁcantly. The results
obtained are summarised in Table 2.
The aetiology of meningococcal disease was
conﬁrmed by PCR, culture and LA for 14 (38%)
patients, by PCR and culture for nine (24%)
patients, and by PCR and LA for two
(5%) patients. For 12 (32%) patients, PCR was
the only method that yielded a positive result.
Table 3 summarises the relationship between the
test results and the form of meningococcal disease
(i.e., sepsis or meningitis).
Figs 1 and 2 illustrate the period following
initiation of antibiotic treatment after which pos-
itive PCR results were obtained with CSF and
blood samples. The last positive CSF sample was
detected on day 7 (Fig. 1), while the last positive
blood sample was detected on day 5 (Fig. 2).
Meningococcal DNA was detected by the group-
speciﬁc primers until day 7 in CSF, and until day
2 in blood. With semi-nested PCR, positive results
were obtained until day 6 in CSF, and until day 5
in blood. The low number of samples did not
permit statistical evaluation of these results.
DISCUSSION
A PCR method for detection of N. meningitidis
serogroups B and C [4] was introduced in 2000 by
the National Reference Laboratory for Meningo-
Table 2. Inﬂuence of antibiotic therapy on the result by
diagnostic method in blood and cerebrospinal ﬂuid (CSF)
Testa Tests done Positive (%) p value
Collection of CSF samples
Before onset
of antibiotic treatment
PCR
LA
21
15
21 (100)
9 (60)
Culture 23 12 (52)
After onset
of antibiotic treatment
PCR
LA
16
9
13 (81)
2 (22)
0.07
0.10
Culture 14 1 (7) 0.01
Collection of blood samples
Before onset
of antibiotic treatment
PCR
LA
17
12
8 (47)
5 (42)
Culture 26 12 (46)
After onset
of antibiotic treatment
PCR
LA
20
14
9 (45)
4 (29)
1.00
0.68
Culture 10 2 (20) 0.25
LA, latex agglutination test.
aFor CSF, only the ﬁrst samples collected on the day of admission were included. A
combination of one-step and semi-nested PCR was used.
Table 3. Positive results of PCR, latex agglutination (LA)
and culture for cerebrospinal ﬂuid (CSF) and blood
samples, grouped in relation to the clinical form of
invasive meningococcal disease
Clinical
presentation
PCR-positivea
n (%)
LA-positivea
n (%)
Culture-positivea
n (%)
CSF Blood CSF Blood CSF Blood
Sepsis 7 (78) 7 (88) 0 0 1 (11) 3 (33)
Meningitis 27 (100) 11 (40) 12 (57) 9 (43) 12 (43) 11 (41)
aAll positive results, independent of timing of collection, are included.
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coccal Infections, Prague, and provides high
sensitivity (85%) and speciﬁcity (95%) [12]. The
original method was modiﬁed as described by
Zambardi et al. [13] and makes use of the primers
described by Frosh et al. [14]. Subsequently, the
method has been upgraded to detect simulta-
neously N. meningitidis, Streptococcus pneumoniae
and Haemophilus inﬂuenzae [2,15]. In 2003, the
National Reference Laboratory participated in an
inter-laboratory comparison of PCR-based identi-
ﬁcation of N. meningitidis, which achieved a mean
sensitivity and speciﬁcity of 90% and 93%,
respectively [16].
The combined PCR method used in the present
study was more reliable than culture and LA for
the diagnosis of IMD. In 12 (32%) cases, the
aetiology was identiﬁed only by PCR. Three cases
were conﬁrmed subsequently by multilocus
sequence typing direct from CSF [17]. The other
nine cases displayed the typical clinical course of
the disease and no other agent was detected. The
present study conﬁrms the importance of PCR for
identifying the aetiology in cases of IMD, with a
signiﬁcant increase in the number of laboratory-
conﬁrmed cases of meningococcal disease.
Almost half the patients in the present study
received antibiotics before hospital admission,
and PCR was particularly useful with such
patients.
Previous studies have reported variable ﬁnd-
ings on the duration of detection by PCR of
meningococcal DNA after antibiotic treatment.
Ragunathan et al. [18] reported that blood and
CSF were PCR-positive for 24 h and 72 h, respect-
ively, after the start of antibiotic therapy, while
Bryant et al. [19] obtained positive nested and
real-time PCR results with blood samples up to
day 9 after the start of intravenous antibiotics. The
present study detected meningococcal DNA up to
day 7 in CSF, and up to day 5 in blood after the
start of antibiotic therapy. The results reﬂect the
fact that DNA persists after bacteria have been
killed, and that clearance of meningococcal DNA
from CSF is slower than from blood. Differences
in results among these studies may be explained
by several factors, including: (1) the number of
bacteria in CSF at the beginning of treatment; (2)
the susceptibility of bacteria to antibiotics; (3) the
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Fig. 1. Period after the initiation of
antimicrobial therapy during which
PCR-positive results were obtained
with cerebrospinal ﬂuid samples
(white, negative results; black, pos-
itive results).
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Fig. 2. Period after the initiation of
antimicrobial therapy during which
PCR-positive results were obtained
with blood samples (white, negative
results; black, positive results).
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number and killing activity of leukocytes in CSF
(leukocytes destroy bacterial DNA after phagocy-
tosis and bacterial lysis); and (4) the permeability
of the blood–brain barrier, which inﬂuences pen-
etration of antibiotics and the immune reaction
components, as well as clearance of bacterial
residues. As the overall detection rate for PCR
decreases during the course of disease, it is
recommended that biological samples (especially
CSF) be taken for PCR investigation as soon as
possible. Nevertheless, despite the availability
and usefulness of PCR for identifying the aetio-
logy in cases of IMD, culture of CSF and blood
remains indispensable for antibiotic sensitivity
testing and for further detailed research into
strains of meningococci.
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